AbbVie
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.

Year Established: 2013
Stock Ticker: ABBV
Exchange: NYSE
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
Abbvie, formerly Celsius Therapeutics, is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.
AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world’s greatest health challenges.